‘Super Aspirin’ could net firm €500m bonanza

A CORK company has developed a side-effect-free aspirin which is expected to generate millions of euro over 10 years.

‘Super Aspirin’ could net firm €500m bonanza

It is in early-stage talks with a number of multinational pharmaceutical companies based in Cork regarding the development of the drug it has named Super Aspirin.

It expects the product to be on sale in the next two years, pending regulatory approval and sales are anticipated to hit €500 million by 2020.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited